PAA 2.38% 21.5¢ pharmaust limited

Ann: Results show MPL suppresses biomarkers associated with MND, page-201

  1. 11,889 Posts.
    lightbulb Created with Sketch. 6036
    RCE just published their Phase I Data Review ,, A comprehensive overview of their Phase I Clinical Trials,,, up 11c ,, Easy To Read , full of Valuable Factual Information, clear and concise , simple Graphs and Charts...

    This is exactly what PAA is absolutely Lacking ,,, I invite you all to read it and see how a Biotech Delivers Data...Tell me I'm wrong
    https://stocknessmonster.com/announcements/rce.asx-6A1158991/

    That's how you get the Oppies in the money NZT
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
0.005(2.38%)
Mkt cap ! $95.68M
Open High Low Value Volume
21.0¢ 21.5¢ 20.5¢ $85.59K 405.8K

Buyers (Bids)

No. Vol. Price($)
8 188925 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 180688 3
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.